DSM has acquired Midori USA, a biotech start-up that develops targeted eubiotics. Midori develops glycans derived from natural food sugars to precisely modulate how the gut microbiome functions in animals. The consistent impact of the glycans on gut health, lead to improved nutrient utilization fro...

DSM has acquired Midori USA, a biotech start-up that develops targeted eubiotics. Midori develops glycans derived from natural food sugars to precisely modulate how the gut microbiome functions in animals. The consistent impact of the glycans on gut health, lead to improved nutrient utilization fro...

DSM has acquired Midori USA, a biotech start-up that develops targeted eubiotics. Midori develops glycans derived from natural food sugars to precisely modulate how the gut microbiome functions in animals. The consistent impact of the glycans on gut health, lead to improved nutrient utilization fro...

DSM has acquired Midori USA, a biotech start-up that develops targeted eubiotics. Midori develops glycans derived from natural food sugars to precisely modulate how the gut microbiome functions in animals. The consistent impact of the glycans on gut health, lead to improved nutrient utilization fro...

DSM has acquired Midori USA, a biotech start-up that develops targeted eubiotics. Midori develops glycans derived from natural food sugars to precisely modulate how the gut microbiome functions in animals. The consistent impact of the glycans on gut health, lead to improved nutrient utilization fro...

DSM has acquired Midori USA, a biotech start-up that develops targeted eubiotics. Midori develops glycans derived from natural food sugars to precisely modulate how the gut microbiome functions in animals. The consistent impact of the glycans on gut health, lead to improved nutrient utilization fro...

DSM has acquired Midori USA, a biotech start-up that develops targeted eubiotics. Midori develops glycans derived from natural food sugars to precisely modulate how the gut microbiome functions in animals. The consistent impact of the glycans on gut health, lead to improved nutrient utilization fro...

DSM has acquired Midori USA, a biotech start-up that develops targeted eubiotics. Midori develops glycans derived from natural food sugars to precisely modulate how the gut microbiome functions in animals. The consistent impact of the glycans on gut health, lead to improved nutrient utilization fro...